Annexin A2 genetics and unexplained stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at certain genetic variations (specifically in a gene called Annexin A2) in people who have had a stroke with no known cause. It aims to understand if these genetic differences might be linked to this type of stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had an ischemic stroke that lasted for more than 24 hours (not a mini-stroke).
- You are at least 18 years old.
- You are not currently pregnant.
- The cause of your stroke is not yet known (cryptogenic).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic factors that may affect stroke recovery. If you had a first ischemic stroke in the past year, you may be able to join and help researchers understand how genes influence outcomes.
This study looks at how genes and life factors may contribute to a type of stroke caused by bleeding in the brain. You may be eligible if you’ve had a spontaneous (not caused by injury or infection) brain bleed and can complete consent, interviews, blood pressure checks, and a DNA sample.
This study looks at how a substance called cell-free DNA in the blood changes in people with a large blood clot causing a stroke. It aims to improve understanding of this condition and might help with future treatments.
This trial tests whether a quick genetic test can help choose the right antiplatelet medicine for people who have had a mild stroke or a high-risk mini-stroke (TIA). The goal is to see if this personalized approach is possible in a hospital setting.
This study tests how a blood sample can help doctors better understand Antiphospholipid Syndrome (APS) by measuring a protein called Annexin A2 on white blood cells. It may lead to easier diagnosis and monitoring of this condition.
This study looks at genetic (inherited DNA) factors in people with certain abnormal blood vessel connections in the brain or spinal cord. It may help researchers understand why these malformations happen and how they might behave over time.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.